Salutem Pharmaceuticals Private Limited

Salutem Pharmaceuticals Private Limited - pharma in Jammu, Jammu And Kashmir, India. FY 2026 financials & compliance.
CIN U24290JK2016PTC009772 Incorporated 13 October 2016 ROC Jammu HQ Jammu, Jammu And Kashmir, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹24.85 Lakh
▲ 4% YoY
Net profit · FY 2025
₹6.5 Lakh
Net margin 26.2%
EBITDA · FY 2025
₹8.9 Lakh
EBITDA margin 35.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered

About Salutem Pharmaceuticals Private Limited

Data last updated:

Salutem Pharmaceuticals Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 October 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24290JK2016PTC009772. Its GSTIN is 05AAXCS8270J1ZK (Uttarakhand). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sahil Mahajan and Mandeep Singh Bhamra.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hall No. 211 B – 1 2nd Floor North Block Bahu Plaza, Jammu, Jammu and Kashmir, India – 180012.

As per the financials filed for FY 2025, the company reported a revenue of ₹24.85 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹6.5 Lakh (net margin 26.2%) and EBITDA of ₹8.9 Lakh (EBITDA margin 35.8%). Revenue has declined at a compounded annual rate (CAGR) of 48% over three years and 36% over five years.

Salutem Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-07-0002284). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24290JK2016PTC009772
Registration Number 009772
Incorporation Date 13 October 2016
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-JK-07-0002284
Key People
Sahil Mahajan Director Mandeep Singh Bhamra Director

Recognitions & Rankings of Salutem Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-JK-07-0002284

Contact details

Salutem Pharmaceuticals Private Limited's registered office is in Jammu, Jammu And Kashmir. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Hall No. 211 B – 1 2nd Floor North Block Bahu Plaza, Jammu, Jammu and Kashmir, India – 180012
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Salutem Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Salutem Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Salutem Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Salutem Pharmaceuticals Private Limited, buy the company report.

Financials of Salutem Pharmaceuticals Private Limited

FY 2025 filings available

Salutem Pharmaceuticals Private Limited reported revenue of ₹24.85 Lakh (up 4% YoY) for FY 2025.

Revenue · FY 2025
₹24.85 Lakh ▲ 4%
Net profit · FY 2025
₹6.5 Lakh margin 26.2%
EBITDA · FY 2025
₹8.9 Lakh margin 35.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 48%
5 years · compounded
▼ 36%
EBITDA CAGR growth
3 years · compounded
▼ 32%
5 years · compounded
▼ 31%

Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 36%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹8.9 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.5 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin35.8%
Net Profit Margin26.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Salutem Pharmaceuticals Private Limited, buy the company report.

Board of directors of Salutem Pharmaceuticals Private Limited

Salutem Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sahil Mahajan
Also directs: Salutemlab Formulations Private Limited, Salutemlife Sciences Private Limited, Polycoatt Films Private Limited and 5 more
Director13 Oct 201610 Years 0 MonthsCurrent
Mandeep Singh Bhamra
Also directs: Ravenbhel Health Care Private Limited
Director17 Jul 20215 Years 3 MonthsCurrent
View all directors

Peer comparison

Salutem Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
108 Avp Technologies Private Limited₹24.87 Lakh (FY 2024)187.0%New Delhi, Delhi, India
Salutem Pharmaceuticals Private Limitedthis company₹24.85 Lakh (FY 2025)₹6.5 Lakh26.2%4.0%Jammu, Jammu And Kashmir, India
Byprio Pharmaceuticals Private Limited₹24.84 Lakh (FY 2025)54.0%Pune, Maharashtra, India
Bright Health Pharmaceuticals Private Limited₹24.83 Lakh (FY 2025)58.0%Bareilly, Uttar Pradesh, India
Raush Pharmaceuticals Private Limited₹24.79 Lakh (FY 2025)-11.0%Ambala Cantt, Haryana, India

To see the full peer comparison of Salutem Pharmaceuticals Private Limited, buy the company report.

Auditor

Salutem Pharmaceuticals Private Limited is audited by SANJEEV ARORA & CO for the financial year 2018.

Auditor firmFinancial yearFirm registration number
SANJEEV ARORA & COFY 2018014451N

Shareholding

The shareholding of Salutem Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Salutem Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Salutem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Salutem Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
05AAXCS8270J1ZKUttarakhandActive01 Jul 2017
11AAXCS8270J1ZRSikkimActive01 Feb 2018

To see the full GST registrations and return filing status of Salutem Pharmaceuticals Private Limited, buy the company report.

Recent activity

Salutem Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Mandeep Singh Bhamra ceased to be Additional Director on 30 Nov 2021.

AGM
Salutem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Salutem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Ceased
Mandeep Singh Bhamra ceased to be Additional Director.
Appointed
Mandeep Singh Bhamra was appointed as Director.
Ceased
Alok Jain Kumar ceased to be Additional Director.
Ceased
Sameer Goel ceased to be Director.
Appointed
Sahil Mahajan was appointed as Director.
Incorporation
13 Oct 2016
Salutem Pharmaceuticals Private Limited was registered on 13 Oct 2016 with Roc Jammu & aged 10 years 26 days as per MCA records.

Frequently asked questions

Salutem Pharmaceuticals is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 October 2016 (10+ years old) and is registered under CIN U24290JK2016PTC009772.

Salutem Pharmaceuticals has 2 current directors:

The latest financial statements of Salutem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Salutem Pharmaceuticals is 05AAXCS8270J1ZK, registered in Uttarakhand. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 11AAXCS8270J1ZR (Sikkim).

The CIN (Corporate Identification Number) of Salutem Pharmaceuticals is U24290JK2016PTC009772. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Salutem Pharmaceuticals was incorporated on 13 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jammu.

The peers of Salutem Pharmaceuticals by revenue are 108 Avp Technologies Private Limited, Byprio Pharmaceuticals Private Limited, Bright Health Pharmaceuticals Private Limited, Raush Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Mandeep Singh Bhamra ceased to be Additional Director on 30 Nov 2021. Mandeep Singh Bhamra was appointed as Director on 17 Jul 2021. Alok Jain Kumar ceased to be Additional Director on 30 Dec 2017. Salutem Pharmaceuticals has 5 board changes on record in total.

Yes, Salutem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-07-0002284).

The registered office of Salutem Pharmaceuticals is at Hall No. 211 B – 1 2nd Floor North Block Bahu Plaza, Jammu, Jammu and Kashmir, India – 180012.

Salutem Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.